The rapid-sequence intravenous urogram was abnormal in one or more parameters in 25 of 26 subjects with unilateral main-renal-artery lesions, in 6 of 7 with bilateral main-renal-artery lesions and ...
In a recently published article in Annals of Emergency Medicine, Firat Bektas and colleagues from Akdeniz University, in Antalya, Turkey, conducted a randomized placebo-controlled trial comparing ...
Background: Hyperhomocysteinaemia is an independent cardiovascular risk factor in patients with renal disease. The current study aimed to determine the effect of intravenous N-acetylcysteine on ...
Trials that compared sodium bicarbonate and sodium chloride for the prevention of contrast-induced acute kidney injury have ... relative efficacy of these two intravenous fluids.
HealthDay on MSN4d
FDA Approves TNKase for Acute Ischemic Stroke(HealthDay News) — The US Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
Revelation Biosciences doses first patient in PRIME phase 1b study of Gemini in CKD patients: San Diego, California Friday, February 28, 2025, 18:00 Hrs [IST] Revelation Bioscienc ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback